HPLC method for determination of in vitro delivery through and into porcine skin of adefovir (PMEA).

[1]  Shufeng Zhou,et al.  Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study. , 2005, Rapid communications in mass spectrometry : RCM.

[2]  J. Zbytovská,et al.  Amphiphilic transdermal permeation enhancers: structure-activity relationships. , 2005, Current medicinal chemistry.

[3]  M. Danta,et al.  Adefovir dipivoxil: review of a novel acyclic nucleoside analogue , 2004, International journal of clinical practice.

[4]  Christine R. Xu,et al.  Ultra sensitive method for the determination of 9-(2-phosphonylmethoxyethyl)adenine in human serum by liquid chromatography-tandem mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  Fabio Garofolo,et al.  Bioanalytical Method Validation , 2004 .

[6]  E. De Clercq,et al.  Transport, Uptake, and Metabolism of the Bis(pivaloyloxymethyl)-Ester Prodrug of 9-(2- Phosphonylmethoxyethyl)Adenine in an In Vitro Cell Culture System of the Intestinal Mucosa (Caco-2) , 1997, Pharmaceutical Research.

[7]  K. A. Mattes,et al.  Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection. , 2003, Clinical therapeutics.

[8]  S. Santoyo,et al.  Optimization of topical cidofovir penetration using microparticles. , 2002, International journal of pharmaceutics.

[9]  S. Santoyo,et al.  Determination of cidofovir in both skin layers and percutaneous penetration samples by HPLC. , 2002, Journal of pharmaceutical and biomedical analysis.

[10]  G. Boivin,et al.  Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy , 2002, Journal of medical virology.

[11]  M. Magnani,et al.  Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus. , 2001, The Journal of antimicrobial chemotherapy.

[12]  A. Valentijn,et al.  Novel hepatotrophic prodrugs of the antiviral nucleoside 9‐(2‐phosphonylmethoxyethyl)adenine with improved pharmacokinetics and antiviral activity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  J. Beijnen,et al.  Improved and simplified liquid chromatographic assay for adefovir, a novel antiviral drug, in human plasma using derivatization with chloroacetaldehyde. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[14]  J. Shaw,et al.  Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[15]  C. Perno,et al.  Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines. , 1996, Molecular pharmacology.

[16]  E. De Clercq,et al.  Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. , 1995, Antiviral research.

[17]  A. Collier,et al.  Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients , 1995, Antimicrobial agents and chemotherapy.

[18]  J. Shaw,et al.  Oral, subcutaneous, and intramuscular bioavailabilities of the antiviral nucleotide analog 9-(2-phosphonylmethoxyethyl) adenine in cynomolgus monkeys , 1994, Antimicrobial Agents and Chemotherapy.

[19]  E. De Clercq,et al.  Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo , 1989, Antimicrobial Agents and Chemotherapy.

[20]  T. Franz.  Percutaneous absorption on the relevance of in vitro data. , 1975, The Journal of investigative dermatology.